Table of Contents
1.1 List of Tables 5
1.2 List of Figures 9
2 Introduction 10
2.1 Spinal Cord Stimulators (SCS) Overview 10
3 Products under Development 11
3.1 Spinal Cord Stimulators (SCS) – Pipeline Products by Stage of Development 11
3.2 Spinal Cord Stimulators (SCS) – Pipeline Products by Territory 12
3.3 Spinal Cord Stimulators (SCS) – Pipeline Products by Regulatory Path 13
3.4 Spinal Cord Stimulators (SCS) – Pipeline Products by Estimated Approval Date 14
3.5 Spinal Cord Stimulators (SCS) – Ongoing Clinical Trials 15
4 Spinal Cord Stimulators (SCS) – Pipeline Products under Development by Companies 16
4.1 Spinal Cord Stimulators (SCS) Companies – Pipeline Products by Stage of Development 16
4.2 Spinal Cord Stimulators (SCS) – Pipeline Products by Stage of Development 17
5 Spinal Cord Stimulators (SCS) Companies and Product Overview 19
5.1 Boston Scientific Corp Company Overview 19
5.1.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 19
5.2 Cerevast Therapeutics Inc Company Overview 20
5.2.1 Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 20
5.3 Direct Spinal Therapeutics, Inc. Company Overview 21
5.3.1 Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.4 Duke University Company Overview 22
5.4.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 22
5.5 GTX Medical BV Company Overview 23
5.5.1 GTX Medical BV Pipeline Products & Ongoing Clinical Trials Overview 23
5.6 Imperial College London Company Overview 29
5.6.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 29
5.7 Lawson Health Research Institute Company Overview 30
5.7.1 Lawson Health Research Institute Pipeline Products & Ongoing Clinical Trials Overview 30
5.8 Meagan Medical Inc. Company Overview 31
5.8.1 Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
5.9 Medtronic plc Company Overview 34
5.9.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 34
5.10 Micro-Leads Inc Company Overview 37
5.10.1 Micro-Leads Inc Pipeline Products & Ongoing Clinical Trials Overview 37
5.11 MicroTransponder Inc Company Overview 39
5.11.1 MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview 39
5.12 Neuronoff Inc Company Overview 40
5.12.1 Neuronoff Inc Pipeline Products & Ongoing Clinical Trials Overview 40
5.13 Nevro Corp Company Overview 41
5.13.1 Nevro Corp Pipeline Products & Ongoing Clinical Trials Overview 41
5.14 Nexstim Plc Company Overview 60
5.14.1 Nexstim Plc Pipeline Products & Ongoing Clinical Trials Overview 60
5.15 Nuvectra Corp Company Overview 61
5.15.1 Nuvectra Corp Pipeline Products & Ongoing Clinical Trials Overview 61
5.16 Saluda Medical Pty Ltd Company Overview 62
5.16.1 Saluda Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 62
5.17 Soterix Medical Inc Company Overview 65
5.17.1 Soterix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 65
5.18 SpineX Company Overview 72
5.18.1 SpineX Pipeline Products & Ongoing Clinical Trials Overview 72
5.19 St. Jude Medical LLC Company Overview 73
5.19.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 73
5.20 University of California Los Angeles Company Overview 77
5.20.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 77
5.21 University of Minnesota Company Overview 79
5.21.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 79
5.22 Wavegate Technologies LLC Company Overview 82
5.22.1 Wavegate Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 82
5.23 WISE s.r.l. Company Overview 83
5.23.1 WISE s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 83
6 Spinal Cord Stimulators (SCS)- Recent Developments 84
6.1 Nov 25, 2019: Stimwave Technologies halts commercialization of product line in Australia 84
6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 84
6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 86
6.4 Nov 12, 2019: Nuvectra continuing to support current patients with the Algovita Implant as company voluntarily files for chapter 11 88
6.5 Nov 08, 2019: University of Wisconsin Madison: Injectable, flexible electrode could replace rigid nerve-stimulating implants 88
7 Appendix 149
7.1 Methodology 149
7.2 About GlobalData 152
7.3 Contact Us 152
7.4 Disclaimer 152
Table 1: Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development
Table 2: Spinal Cord Stimulators (SCS) - Pipeline Products by Territory
Table 3: Spinal Cord Stimulators (SCS) - Pipeline Products by Regulatory Path
Table 4: Spinal Cord Stimulators (SCS) - Pipeline Products by Estimated Approval Date
Table 5: Spinal Cord Stimulators (SCS) - Ongoing Clinical Trials
Table 6: Spinal Cord Stimulators (SCS) Companies - Pipeline Products by Stage of Development
Table 7: Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development
Table 8: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Next Generation SCS System - Product Status
Table 10: Next Generation SCS System - Product Description
Table 11: Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Transdermal Electrical Neurostimulation Device - Product Status
Table 13: Transdermal Electrical Neurostimulation Device - Product Description
Table 14: Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Iowa-Patch System - Product Status
Table 16: Iowa-Patch System - Product Description
Table 17: Duke University Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Spinal Cord Stimulator - Product Status
Table 19: Spinal Cord Stimulator - Product Description
Table 20: GTX Medical BV Pipeline Products & Ongoing Clinical Trials Overview
Table 21: External Transcutaneous Spinal Cord Stimulation Device - Product Status
Table 22: External Transcutaneous Spinal Cord Stimulation Device - Product Description
Table 23: Targeted Epidural Spinal Stimulation Device - Product Status
Table 24: Targeted Epidural Spinal Stimulation Device - Product Description
Table 25: GTX Medical BV - Ongoing Clinical Trials Overview
Table 26: External Transcutaneous Spinal Cord Stimulation Device - Activity Dependent Rehabilitation Via Transcutaneous Electrical Spinal Stimulation to Restore Upper Extremity Functions in Spinal Cord Injury
Table 27: Targeted Epidural Spinal Stimulation Device - Efficacy of Spinal Epidural Electrical Stimulation (EES) in Combination with Robot-assisted Neurorehabilitation in Patients with Spinal Cord Injury (STIMO)
Table 28: Targeted Epidural Spinal Stimulation Device - Enabling Forelimb Function with Agonist Drug and Epidural Stimulation in SCI
Table 29: Targeted Epidural Spinal Stimulation Device - Targeting Improvements in Bowel Function and Quality of Life Using Epidural Stimulation and Training After Severe Spinal Cord Injury
Table 30: Targeted Epidural Spinal Stimulation Device - Task and Physiological Specific Stimulation for Recovery of Autonomic Function, Voluntary Movement, and Standing Using Epidural Stimulation and Training After Severe Spinal Cord Injury
Table 31: Targeted Epidural Spinal Stimulation Device - Task-specific Epidural Stimulation and Training for Recovery of Stepping, Standing and Voluntary Movement Following Severe Spinal Cord Injury
Table 32: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Wireless Intraspinal Microstimulation System - Product Status
Table 34: Wireless Intraspinal Microstimulation System - Product Description
Table 35: Lawson Health Research Institute Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Spinal Implant - Parkinson’s Disease - Product Status
Table 37: Spinal Implant - Parkinson’s Disease - Product Description
Table 38: Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 39: DISCSS IFC System - Product Status
Table 40: DISCSS IFC System - Product Description
Table 41: Meagan Medical Inc. - Ongoing Clinical Trials Overview
Table 42: DISCSS IFC System - Pilot Study to Examine the Feasibility of the DISCSS
Table 43: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 44: MRI Surgical Lead - Product Status
Table 45: MRI Surgical Lead - Product Description
Table 46: Next Generation Intellis - Product Status
Table 47: Next Generation Intellis - Product Description
Table 48: PrimeADVANCED - Heart Failure - Product Status
Table 49: PrimeADVANCED - Heart Failure - Product Description
Table 50: Micro-Leads Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 51: HD64 Implantable Therapy System - Product Status
Table 52: HD64 Implantable Therapy System - Product Description
Table 53: Intelligent Spinal Interface - Product Status
Table 54: Intelligent Spinal Interface - Product Description
Table 55: MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 56: SAINT System - Chronic Pain - Product Status
Table 57: SAINT System - Chronic Pain - Product Description
Table 58: Neuronoff Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Injectrode - Product Status
Table 60: Injectrode - Product Description
List of Figures
Figure 1: Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development
Figure 2: Spinal Cord Stimulators (SCS) - Pipeline Products by Territory
Figure 3: Spinal Cord Stimulators (SCS) - Pipeline Products by Regulatory Path
Figure 4: Spinal Cord Stimulators (SCS) - Pipeline Products by Estimated Approval Date
Figure 5: Spinal Cord Stimulators (SCS) - Ongoing Clinical Trials
【免責事項】
https://www.marketreport.jp/reports-disclaimer